Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 172

The DOI matches its Crossref record.

Individualized dose titration of growth hormone (GH) during GH replacement in hypopituitary adults

Johannsson, Gudmundur, Rosén, Thord, Bengtsson, Bengt‐Åke · 1997 · Clinical Endocrinology

Abstract

OBJECTIVE: Until now, GH treatment in GH‐deficient adults has employed dose schedules of GH based on body weight or body surface area and has ignored individual responsiveness to GH. This trial has studied the effects of an individualized GH dose adjusted to match a combination of clinical response, normalization of serum IGF‐I concentration and body composition. DESIGN AND PATIENTS: Two closely‐matched groups, each comprising 30 GH‐deficient adults, 38 men and 22 women aged 48 years, were treated with GH for 12 months. The high dose (HD) group received a target dose of 12 μg/kg per day and the individualized dose (ID) group received an initial daily GH dose of 0.17 or 0.33 mg per day (0.5 and 1 IU, respectively), independent of body weight, with dose adjustments thereafter. MEASUREMENTS: Serum concentrations of IGF‐I, lipoprotein(a), insulin, calcium, intact PTH, osteocalcin and blood glucose were measured. Body composition was determined according to a 4‐compartment model using total body potassium and tritiated water as input variables. Total body nitrogen was measured by in vivo neutron activation and total body bone mineral content by dual energy X‐ray absorptiometry. RESULTS: At 12 months, the daily dose of GH was 0.55 ± 0.03 mg and 0.45 ± 0.03 mg in the HD and ID groups, respectively (P < 0.05). In the HD group, the mean serum IGF‐I increased to levels well above the predicted level, while in the ID group the mean serum IGF‐I normalized. Side‐effects were experienced by 70% of the subjects in the HD group and by 30% in the ID group (P < 0.001). A similar response to GH in terms of body composition, glucose homeostasis, lipoprotein(a) and blood pressure was obtained in both treatment groups. However, the treatment response in terms of serum calcium, intact PTH and osteocalcin was more marked in the HD group. CONCLUSIONS: Similar efficacy, with a lower dose of GH and fewer side‐effects, was obtained by considering individual responsiveness to GH as compared to higher doses of GH adjusted to match body weight.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1365-2265.1997.3271123.x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 172

Metadata

Authors
Johannsson, G., Rosén, T., & Bengtsson, B.
Venue
Clinical Endocrinology
Publisher
Wiley
Published
1997-11
Volume
47
Issue
5
Pages
571-581
ISSN
  • 0300-0664 (ISSN-L)
  • 1365-2265
OpenAlex
W2020108509
Cited by
172
References
0
FWCI
7.96
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Individualized dose titration of growth hormone (GH) during GH replacement in hypopituitary adults. https://app.cochat.ai/papers/10.1046/j.1365-2265.1997.3271123.x
The paper
Johannsson, G., Rosén, T., & Bengtsson, B. (1997). Individualized dose titration of growth hormone (GH) during GH replacement in hypopituitary adults. Clinical Endocrinology. https://doi.org/10.1046/j.1365-2265.1997.3271123.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.